The Initial Validation of a Markov Model for the Economic Evaluation of (New) Treatments for Rheumatoid Arthritis

By Welsing Paco M.J.  

PharmacoEconomics, Vol. 24, Iss. 10, 2006-01 ,pp. : 1011-1020

Adis International

Access to resources Recommend Favorite

A Lifetime Markov Model for the Economic Evaluation of Chronic Obstructive Pulmonary Disease

By Menn Petra   Leidl Reiner   Holle Rolf  

PharmacoEconomics, Vol. 30, Iss. 9, 2012-09 ,pp. : 825-840

Adis International

Access to resources Recommend Favorite

Recent Developments in Decision-Analytic Modelling for Economic Evaluation

By Weinstein Milton C.  

PharmacoEconomics, Vol. 24, Iss. 11, 2006-01 ,pp. : 1043-1053

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting: An Economic Markov Model Evaluation

By Haycox Alan  

Drugs & Aging, Vol. 26, Iss. 9, 2009-09 ,pp. : 791-801

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rasagiline and Pramipexole as Treatment Strategies in Early Parkinson's Disease in the UK Setting:: An Economic Markov Model Evaluation

By Kovacs Norbert   Janszky Jozsef   Nagy Ferenc  

Drugs & Aging, Vol. 28, Iss. 2, 2011-02 ,pp. : 161-162

Adis International

Access to resources Recommend Favorite